Macrogen Inc (038290)
KOSDAQ · Korea · prices in KRW · close of 19 Oct 2026
Key indicators
| Last close | KRW 11,590.00 |
|---|---|
| 52-week range | 10,440.00 – 20,900.00 |
| Return, 1 month / 3 months | −1.8% / +0.4% |
| Return, 1 year / 3 years | −23.2% / −35.8% |
| Trend | Below its 200-day average |
| RSI (14) | 43 |
| Volatility (1 year) | 43.5% |
| Worst drawdown (1 year) | -45.2% |
| Average daily value traded | 333.78M KRW |
| Dividend yield | 4.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Macrogen is a biotechnology company based in Korea that provides DNA sequencing and genetic analysis services. It offers sequencing, genotyping and bioinformatics work for research institutions, hospitals, universities and pharmaceutical companies, along with molecular diagnostics and related laboratory services. Its customers use these services in medical research, clinical testing and drug development, and the company also operates overseas branches that serve international research and healthcare markets.
On this site Macrogen Inc appears as a stock on the KOSDAQ (Korea), code 038290, with prices in South Korean won (KRW). Our dividend records, which start in 2019, show payments in 6 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Macrogen Inc (038290) trades on the KOSDAQ in Korea. It last closed at KRW 11,590.00 on 19 October 2026.
Its price-based Market X-Ray is 57 out of 100 (a fair price profile), ranking 706 of 1,830 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 23.2% and over the last three months it rose 0.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on KOSDAQ
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 49 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -19.8% | ||
| From 52-week high | -40.6% | ||
| Momentum | 45 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | 0.4% | ||
| 6-month return | -28.4% | ||
| 12-month return, skipping the last month | -21.8% | ||
| Stability (higher is calmer) | 76 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 43.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -45.2% | ||
| Liquidity | 51 · Fair | Moderate trading activity. | |
| Average daily value traded | 333.78M KRW | ||
| Zero-volume days | 0.0% | ||
| Income | 68 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 4.3% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | −0.8% |
|---|---|
| 1 month | −1.8% |
| 3 months | +0.4% |
| 6 months | −28.4% |
| 1 year | −23.2% |
| 3 years | −35.8% |
| 5 years | – |
Signals
| 50-day / 200-day average | 12,211.60 / 14,452.24 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 405.04 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 29 Dec 2025 | KRW 500.0000 |
| 27 Dec 2024 | KRW 300.0000 |
| 27 Dec 2023 | KRW 300.0000 |
| 28 Dec 2022 | KRW 300.0000 |
| 29 Dec 2021 | KRW 300.0000 |
| 29 Dec 2020 | KRW 300.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on KOSDAQ; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.